Published in Drugs on June 01, 1978
Self-microemulsifying drug-delivery system for improved oral bioavailability of probucol: preparation and evaluation. Int J Nanomedicine (2012) 0.85
Probucol and hypercholesterolaemia. Br J Clin Pharmacol (1981) 0.75
An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer. Drug Des Devel Ther (2014) 0.75
Proceedings of the Fiftieth Anniversary Meeting of the British Pharmacological Society, University of Oxford, 16-18 September 1981. Abstracts. Br J Pharmacol (1981) 0.75
Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections. Drugs (1982) 3.34
Nimesulide. A preliminary review of its pharmacological properties and therapeutic efficacy in inflammation and pain states. Drugs (1988) 2.94
Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure. Drugs (1986) 2.72
Midazolam. A review of its pharmacological properties and therapeutic use. Drugs (1984) 2.60
Ketorolac. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs (1990) 2.29
Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy. Drugs (1980) 2.26
Tiaprofenic acid. A review of its pharmacological properties and therapeutic efficacy in rheumatic diseases and pain states. Drugs (1985) 2.26
Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension. Drugs (1977) 2.17
Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use. Drugs (1978) 2.12
Metoclopramide. An updated review of its pharmacological properties and clinical use. Drugs (1983) 2.02
Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy. Drugs (1993) 1.95
Miconazole: a review of its antifungal activity and therapeutic efficacy. Drugs (1975) 1.93
Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases. Drugs (1982) 1.87
Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections. Drugs (1990) 1.83
Pyrazolone derivatives. Drugs (1986) 1.72
Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias. Drugs (1978) 1.72
Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs (1983) 1.71
Clotrimazole: a review of its antifungal activity and therapeutic efficacy. Drugs (1975) 1.69
Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs (1985) 1.69
Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis. Drugs (1980) 1.67
Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs (1984) 1.65
Flunarizine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use. Drugs (1984) 1.64
Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use. Drugs (1981) 1.64
Metoclopramide: a review of its pharmacological properties and clinical use. Drugs (1976) 1.63
Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin. Drugs (1980) 1.59
Norfloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs (1985) 1.56
Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia. Drugs (1981) 1.55
Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management. Drugs (1997) 1.52
Astemizole. A review of its pharmacodynamic properties and therapeutic efficacy. Drugs (1984) 1.52
Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy. Drugs (1977) 1.52
Nefopam: a review of its pharmacological properties and therapeutic efficacy. Drugs (1980) 1.51
Cimetidine: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease. Drugs (1978) 1.48
Pizotifen (BC-105): a review of its pharmacological properties and its therapeutic efficacy in vascular headaches. Drugs (1972) 1.47
Amlodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease. Drugs (1991) 1.45
Rifaximin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria. Drugs (1995) 1.45
Labetalol: a review of its pharmacology and therapeutic use in hypertension. Drugs (1978) 1.44